Glenn P. Muir
Director · Cytek Biosciences, Inc.
Individual
- 2024
- Aug 20, 2026
- 10
Other insiders active in the same sector
No other insider has filed at Glenn P. Muir's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Glenn P. Muir?
Glenn P. Muir is a corporate insider, tracked as Director of Cytek Biosciences, Inc. (CTKB). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Glenn P. Muir submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
